Dr. Chavannes received her MD degree at McGill University, Montreal, Quebec, Canada, in 2011. She then completed her residency in pediatric at the University of Western Ontario, in London, Ontario, Canada, in 2014. She successfully completed her pediatric gastroenterology fellowship at the University of Montreal, Quebec, Canada in 2016. Dr. Chavannes completed her Masters of Health Science in Epidemiology and one year of Advanced Inflammatory Bowel Disease Fellowship at the University of British Columbia, Vancouver, Canada in December 2017.
Dr. Chavannes, research focus has been on the evaluation of therapies in inflammatory bowel diseases. Her paper on “The Assessment of the use of therapeutic drug monitoring of Adalimumab during maintenance therapy in children with Inflammatory Bowel Disease” was presented both at ECCO (European Crohn’s & Colitis Organization) meeting in Barcelona in 2017 and at DDW in Chicago in May 2017. Her research interest is in finding non-invasive ways of monitoring disease activity in children with inflammatory bowel disease.